Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abecma, ATM, aware, catastrophic, Century, clearance, climate, collateral, Columbia, confidence, Delta, downturn, entry, enumerated, escape, exacerbate, fire, formally, fourteen, freestanding, gene, geopolitical, halt, Hedging, ID, idecabtagene, instability, Instruction, month, NaN, Omicron, political, promulgated, regenerative, regional, resale, rescinded, retaliatory, RMAT, stipulated, Subtopic, tension, terrorism, terrorist, thirty, twenty, Ukraine, unexercised, vicleucel, Wainwright, weak, weigh
Removed:
absence, achieved, Alexey, Andreevich, assign, calculating, commensurate, comprised, core, cridanimod, criterion, dosed, Dr, encapsulation, endometrial, exceeded, explore, hemophilia, histone, hypothesized, identifiable, immunogenic, leader, liposomal, maximize, mediated, merger, naturally, nominated, nonexclusive, opko, progesterone, progestin, programmed, ranging, reassessed, reliable, represented, resistant, retention, rFVIII, RSU, ruling, scale, seller, slower, sodium, sought, title, tolerated, tranche, undisclosed, vesicle, Vinogradov
Filing tables
Filing exhibits
- 10-K Annual report
- 10.3 Novation of Agreement on Co-development and the Terms of Exclusive License, Dated December 17, 2021, Between Xenetic Biosciences (Uk) Limited (Formerly Lipoxen PLC), Lipoxen Technologies Limited, Synbio LLC and Public Joint-stock Company Pharmsynthez
- 10.4 Exclusive License Agreement, Dated December 20, 2021, Between Lipoxen Technologies Limited and Public Joint-stock Company Pharmsynthez
- 10.28 Amendment Number One to the Master Services Agreement, Dated October 12, 2021, Between the Company and PJSC Pharmsynthez
- 10.29 Second Work Order to Master Service Agreement, Dated October 12, 2021, Between the Company and PJSC Pharmsynthez
- 21.1 List of Subsidiaries
- 23.1 Consent of Marcum LLP
- 31.1 Certification of Principal Executive Officer
- 31.2 Certification of Principal Financial Officer
- 32.1 Certification of Principal Executive Officer and Principal Financial Officer
- Download Excel data file
- View Excel data file
XBIO similar filings
Filing view
External links